Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first

Source: www.cnbc.com · Section: business-tech · Bias: Center-Right · Published: Wed, 22 Jul 2026 05:58:51 GMT

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.

Read the full article at www.cnbc.com →

The same story across the political spectrum (15 sources)

Center-Right: China's Zhongji Innolight sees shares surge after Hong Kong listing approval — www.cnbc.com
Center-Left: Scoop: Lawmaker asks SEC to investigate Truth Social's plan to monetize access to its data — www.axios.com
Center: Wall Street steadies as AI stocks recover some of last week losses — capitalgazette.com
Center: Wall Street drifts as AI stocks hold steadier after last week losses — kob.com
Right: Days after Biden inauguration, FBI shielded Wuhan lab collaborator from investigation after China trip — www.theblaze.com
Right: Communist Streamer Hasan Piker Berates Moderates While Dressed as Mao Zedong — www.breitbart.com
Right: Trump administration opens investigation into Harvard's financial aid for international students — www.washingtontimes.com
Right: DOJ opens probe into Harvard's financial aid for alleged discrimination against American students — www.foxnews.com

← Back to FlashTopics.com